CleanSpark Valuation

Is CLSK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CLSK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLSK ($12.37) is trading below our estimate of fair value ($73.82)

Significantly Below Fair Value: CLSK is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLSK?

Other financial metrics that can be useful for relative valuation.

CLSK key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue8.9x
Enterprise Value/EBITDA15.4x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CLSK's PS Ratio compare to its peers?

The above table shows the PS ratio for CLSK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average7.8x
MARA MARA Holdings
9.9x23.9%US$5.6b
IREN Iris Energy
10.6x37.2%US$2.1b
BRZE Braze
6.1x17.7%US$3.2b
DV DoubleVerify Holdings
4.8x14.0%US$3.0b
CLSK CleanSpark
9.2x37.2%US$3.2b

Price-To-Sales vs Peers: CLSK is expensive based on its Price-To-Sales Ratio (9.2x) compared to the peer average (7.8x).


Price to Earnings Ratio vs Industry

How does CLSK's PE Ratio compare vs other companies in the US Software Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.1%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.1%
n/an/an/a
No more companies

Price-To-Sales vs Industry: CLSK is expensive based on its Price-To-Sales Ratio (9.2x) compared to the US Software industry average (4.8x).


Price to Sales Ratio vs Fair Ratio

What is CLSK's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLSK PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio9.2x
Fair PS Ratio9.8x

Price-To-Sales vs Fair Ratio: CLSK is good value based on its Price-To-Sales Ratio (9.2x) compared to the estimated Fair Price-To-Sales Ratio (9.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CLSK forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$12.37
US$22.08
+78.5%
27.8%US$30.00US$10.50n/a6
Oct ’25US$8.61
US$22.08
+156.5%
27.8%US$30.00US$10.50n/a6
Sep ’25US$10.69
US$23.08
+115.9%
26.9%US$30.00US$10.50n/a6
Aug ’25US$15.09
US$24.25
+60.7%
23.9%US$30.00US$12.50n/a6
Jul ’25US$17.92
US$24.08
+34.4%
23.6%US$30.00US$12.50n/a6
Jun ’25US$16.07
US$23.33
+45.2%
21.2%US$30.00US$15.00n/a6
May ’25US$15.65
US$23.33
+49.1%
21.2%US$30.00US$15.00n/a6
Apr ’25US$18.58
US$23.17
+24.7%
22.6%US$30.00US$14.00n/a6
Mar ’25US$17.86
US$15.03
-15.8%
36.8%US$27.00US$10.00n/a6
Feb ’25US$8.36
US$11.87
+41.9%
18.8%US$14.20US$8.00n/a6
Jan ’25US$11.03
US$11.87
+7.6%
18.8%US$14.20US$8.00n/a6
Dec ’24US$7.64
US$10.05
+31.5%
26.7%US$14.00US$5.30n/a6
Nov ’24US$4.14
US$9.97
+140.7%
27.3%US$14.00US$5.30n/a6
Oct ’24US$3.81
US$11.25
+195.3%
14.6%US$14.00US$10.00US$8.614
Sep ’24US$4.57
US$11.25
+146.2%
14.6%US$14.00US$10.00US$10.694
Aug ’24US$5.84
US$9.50
+62.7%
22.9%US$12.00US$6.00US$15.094
Jul ’24US$4.29
US$8.00
+86.5%
30.6%US$12.00US$6.00US$17.924
Jun ’24US$4.32
US$8.00
+85.2%
30.6%US$12.00US$6.00US$16.074
May ’24US$3.42
US$7.75
+126.6%
34.6%US$12.00US$5.00US$15.654
Apr ’24US$2.78
US$7.50
+169.8%
38.3%US$12.00US$5.00US$18.584
Mar ’24US$2.58
US$7.50
+190.7%
38.3%US$12.00US$5.00US$17.864
Feb ’24US$3.24
US$8.00
+146.9%
38.5%US$12.00US$5.00US$8.364
Jan ’24US$2.04
US$8.00
+292.2%
38.5%US$12.00US$5.00US$11.034
Dec ’23US$2.30
US$9.33
+305.8%
26.7%US$12.00US$6.00US$7.643
Nov ’23US$3.26
US$9.33
+186.3%
26.7%US$12.00US$6.00US$4.143
Oct ’23US$3.18
US$10.33
+224.9%
12.1%US$12.00US$9.00US$3.813

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies